A Halving Is Not a Discount: The 3 Hype Stocks Still Priced for Perfection

The most loved story in the stock market this year was written in the stars and the data centers. Rocket Lab was the everyman's answer to SpaceX. AST SpaceMobile would beam cellular service to any ordinary phone. Palantir was the AI toll booth. Each was a "no-brainer" everyone could explain, which is the surest sign the idea has already been bought.

Now come the two facts the groupies prefer not to put in the same sentence. Rocket Lab peaked at $150.23 in May and trades near $63 — down more than half from its high. AST SpaceMobile touched $133.86 and now sits around $60, also roughly halved. Only Palantir has kept its ground, and even it trades below its peak. Three beloved names, two of them in drawdown.

None of this should be a headline. Halving happens to hype. The reflex the crowd reaches for is the one that matters: the damage is done, the thing is on sale, buy the dip. That reflex is wrong, because a crash and a cheap stock are not the same transaction. These companies did not fall from impossible prices to reasonable ones. They fell from impossible prices to merely breathtaking ones — and the gap between those two words is the whole story.

Down 50 percent is not the same as a discount

Check what the halving actually bought you. Rocket Lab still trades for roughly 49 times trailing sales. AST SpaceMobile still fetches about 200 times trailing sales. Palantir sits near 65 times sales and 133 times trailing earnings.

Read those again, because the crash already happened. A stock that halves and still costs fifty, two hundred, or sixty-five times revenue is not a markdown. It is the original wager at a lower sticker price. The step down cut the price, not the multiplier, and the multiplier is what encodes the required future.

The denominator the headlines skip

The celebrated number in all these pitches is revenue growth, and it is real. Rocket Lab's sales are up more than 50 percent year over year. AST's revenues grew thousands of percent — off a base so tiny that the hundred-percent-plus growth is a rounding error on a balance sheet that matters. Palantir is compounding sales near 80 percent.

The economic question is what that growth costs in cash, dilution, and borrowed time. This is where the two space names are really the same company wearing different logos.

Rocket Lab is not profitable: operating margin around negative 33 percent, cash flow negative. Its entire valuation rests on Neutron, the heavy-lift rocket that is supposed to make it a real rival to SpaceX's Falcon. Neutron has slipped to 2027, and in the meantime the company is funding the build the way pre-revenue capital projects always do — with dilution, including an $8 billion Iridium-linked arrangement flagged for dilution risk, alongside equity sales registered this year. Meanwhile SpaceX's June IPO pulled the oxygen out of the sector and made the "we'll price launch however we want" premise harder to believe.

AST SpaceMobile is the same shape on a bigger turn. It spent roughly $1.6 billion on capital expenditures in the last year building the BlueBird constellation, at an operating margin that is deeply, structurally negative. It raised money through convertible notes twice this year, in February and July, and each announcement knocked the stock — the July one by about 13 percent on dilution fears. It needs 45 to 60 satellites in orbit by the end of 2026 to deliver the continuous service the story depends on, and its path to profit still runs through execution that has not happened yet. Investors here are not buying earnings; they are buying a network that must be built and monetized before cash and trust run thin.

The headline metric — revenue growth — answers the easy question ("is the future big?"). The denominator that changes the verdict is capital: how much must be spent and diluted before the promised cash arrives.

The profitable one hides the same shape

Palantir deserves a stronger defense than any skeptic will give it. Gross margin near 85 percent, operating margin in the low 40s, free cash flow margin above 50 percent, and revenue compounding. This is an excellent business, and the bulls are right to say so. That is precisely why it is a bad object lesson to skip.

At 65 times sales and 133 times earnings, the market has not priced success. It has priced success without interruption, imitation, deceleration, or boredom — the demand keeps growing this fast, the customer concentration never bites, no cheaper rival arrives. A small bend in growth or margin is not a five percent problem at this multiple; it is a re-rating. Palantir is the reminder that a genuinely great company can be the wrong stock, because the excellence is already in the price, and there is nothing left for the shares to discover.

What would make the story honest

A contrarian claim earns respect only when it can lose. These prices become defensible if the promised cash actually shows up: Neutron flying with real, contracted revenue instead of a 2027 target; AST monetizing carrier contracts into actual billed service at scale instead of satellite-launch progress; Palantir keeping its margin and growth intact through a full cycle. Execute any of those and the current price, not the doubt, turns out to have been right.

Until then, treat each dip less like a sale and more like the same wager marked down for the buyers who missed the first move. The good news about these businesses can be entirely true, and the trade can still lose money, because other people already paid for that truth. Crowds protect careers; they do not protect capital. The question was never whether the story is real. It is who gets paid after everyone has already paid for it.